Medicinal product name Zecatrin 4 mg prolonged-release tablets
Pharmaceutical form Prolonged-release tablet
Strength 4 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
21-0083-03N30 Is available
Legal status Rx Prescription (Pr.)
Package leafletMS Word document 22-04-2021
Summary of product characteristicsMS Word document 23-11-2021
ATC code G04BD11 Urologicals

Important notice

Additional information regarding the use for persons aged 75+

If used as "UROLOGICALS"
SubstanceClassComment
Fesoterodini fumarasDAvoid use in older persons. Anticholinergic. Reduce the dose in even moderate renal insufficiency. Significant adverse reactions include dry mouth, constipation, urinary difficulties, confusion and cognitive disorder. Take several interactions into account. Weakens the efficacy of anti-Alzheimer`s drugs. Avoid consuming grapefruit during treatment.

Medicinal products (10)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N14
(4 mg)
OPA/Al/PVC/Al blister    21-0083-01 Labelling text Labelling text Apr 22, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N28
(4 mg)
OPA/Al/PVC/Al blister    21-0083-02 Labelling text Labelling text Apr 22, 2021
 Is available (according to the information provided by wholesalers)
(73 containers)
Tamro, Recipe Plus, Magnum Medical N30
(4 mg)
OPA/Al/PVC/Al blister 24.00  21-0083-03 Labelling text Labelling text Apr 22, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N84
(4 mg)
OPA/Al/PVC/Al blister    21-0083-04 Labelling text Labelling text Apr 22, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N100
(4 mg)
OPA/Al/PVC/Al blister    21-0083-05 Labelling text Labelling text Apr 22, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N14: 14 × 1
(4 mg)
OPA/Al/PVC/Al perforated unit dose blister    21-0083-06 Labelling text Labelling text Apr 22, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N28: 28 × 1
(4 mg)
OPA/Al/PVC/Al perforated unit dose blister    21-0083-07 Labelling text Labelling text Apr 22, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30: 30 × 1
(4 mg)
OPA/Al/PVC/Al perforated unit dose blister    21-0083-08 Labelling text Labelling text Apr 22, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N84: 84 × 1
(4 mg)
OPA/Al/PVC/Al perforated unit dose blister    21-0083-09 Labelling text Labelling text Apr 22, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N100: 100 × 1
(4 mg)
OPA/Al/PVC/Al perforated unit dose blister    21-0083-10 Labelling text Labelling text Apr 22, 2021

Registration information

Marketing authorisation No. 21-0083
Date of authorisation Apr 23, 2021
MA valid until Apr 22, 2026
Marketing authorisation holder, country Zentiva, k.s., Czech Republic